Tatva Chintan Pharma Chem Ltd. - Research Center
543321 TATVA Group (B) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Mar ' 21 |
Sales |
198.68 |
170.10 |
203.47 |
224.34 |
180.66 |
Operating profit |
40.35 |
22.43 |
44.86 |
60.99 |
47.35 |
Interest |
5.91 |
2.38 |
2.17 |
2.66 |
2.15 |
Gross profit |
36.21 |
23.43 |
48.96 |
62.49 |
47.97 |
EPS (Rs) |
7.03 |
6.21 |
18.64 |
24.67 |
20.08 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Mar ' 21 |
Other income |
1.77 |
3.38 |
6.27 |
4.16 |
2.77 |
Stock adjustment |
-5.54 |
-23.86 |
-44.92 |
-13.12 |
-5.17 |
Raw material |
93.59 |
108.48 |
134.06 |
118.94 |
90.94 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
25.63 |
17.78 |
16.47 |
14.58 |
14.01 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
44.65 |
45.27 |
53.00 |
42.96 |
33.53 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
12.79 |
4.64 |
4.22 |
3.96 |
3.36 |
Taxation |
6.98 |
5.03 |
3.42 |
3.86 |
4.28 |
Net profit / loss |
16.45 |
13.76 |
41.32 |
54.67 |
40.33 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
23.39 |
22.17 |
22.17 |
22.17 |
20.09 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
20.31 |
13.19 |
22.05 |
27.18 |
26.21 |
GPM (%) |
18.07 |
13.51 |
23.34 |
27.35 |
26.15 |
NPM (%) |
8.21 |
7.93 |
19.70 |
23.93 |
21.99 |